BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression
- 23 March 2017
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 74 (15) , 2827-2838
Abstract
BACE2 (β-site APP-cleaving enzyme 2) is a protease expressed in the brain, but also in the pancreas, where it seems to play a physiological role. Amyloidogenic diseases, including Alzheimer’s disease and type 2 diabetes (T2D), share the accumulation of abnormally folded and insoluble proteins that interfere with cell function. In T2D, islet amyloid polypeptide (IAPP) deposits have been shown to be a pathogenic key feature of the disease. The aim of the present study was to investigate the effect of BACE2 modulation on β-cell alterations in a mouse model of T2D induced by IAPP overexpression. Heterozygous mice carrying the human transcript of IAPP (hIAPP-Tg) were used as a model to study the deleterious effects of IAPP upon β-cell function. These animals showed glucose intolerance and impaired insulin secretion. When crossed with BACE2-deficient mice, the animals presented a significant improvement in glucose tolerance accompanied with an enhanced insulin secretion, as compared to hIAPP-Tg mice. BACE2 deficiency also partially reverted gene expression changes observed in islets from hIAPP-Tg mice, including a set of genes related to inflammation. Moreover, homozygous hIAPP mice presented a severe hyperglycemia and a high lethality rate from 8 weeks onwards due to a massive destruction of β-cell mass. This process was significantly reduced when crossed with the BACE2-KO model, improving the survival rate of the animals. Altogether, the absence of BACE2 ameliorates glucose tolerance defects induced by IAPP overexpression in the β-cell and promotes β-cell survival. Thus, targeting BACE2 may represent a promising therapeutic strategy to improve β-cell function in T2D.Keywords
Funding Information
- Instituto de Salud Carlos III (PI11/00679, PI14/00447)
- Departament d’Innovació, Universitats i Empresa, Generalitat de Catalunya (2014_SGR_520)
This publication has 50 references indexed in Scilit:
- Involvement of ATP-sensitive Potassium (KATP) Channels in the Loss of Beta-cell Function Induced by Human Islet Amyloid PolypeptideJournal of Biological Chemistry, 2011
- Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and MassCell Metabolism, 2011
- BACE2 plays a role in the insulin receptor trafficking in pancreatic β-cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesNature Immunology, 2010
- Identification of β-Secretase (BACE1) Substrates Using Quantitative ProteomicsPLOS ONE, 2009
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and AutostimulationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Impairment of the Ubiquitin-Proteasome Pathway Is a Downstream Endoplasmic Reticulum Stress Response Induced by Extracellular Human Islet Amyloid Polypeptide and Contributes to Pancreatic β-Cell ApoptosisDiabetes, 2007
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006
- Tmem27: A cleaved and shed plasma membrane protein that stimulates pancreatic β cell proliferationCell Metabolism, 2005
- BACE Maps to Chromosome 11 and a BACE Homolog, BACE2 , Reside in the Obligate Down Syndrome Region of Chromosome 21Science, 1999